BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 28786023)

  • 1. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
    Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
    Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.
    Tao L; Wang S; Yang L; Jiang L; Li J; Wang X
    Clin Exp Immunol; 2020 Aug; 201(2):161-170. PubMed ID: 32319079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Frequency of Dysfunctional Siglec-7
    Sakamoto Y; Yoshio S; Doi H; Mori T; Matsuda M; Kawai H; Shimagaki T; Yoshikawa S; Aoki Y; Osawa Y; Yoshida Y; Arai T; Itokawa N; Atsukawa M; Ito T; Honda T; Mise Y; Ono Y; Takahashi Y; Saiura A; Taketomi A; Kanto T
    Front Immunol; 2021; 12():603133. PubMed ID: 33692781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
    Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication.
    Zhao D; Jiang X; Xu Y; Yang H; Gao D; Li X; Gao L; Ma C; Liang X
    Front Immunol; 2018; 9():1124. PubMed ID: 29899741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reduced frequency of natural killer cell on siglec-7(+) is associated with progression of hepatitis B virus-related cirrhosis].
    Li YL; Zhang QF; Yin WW; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):420-425. PubMed ID: 30317754
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired natural killer cell subset phenotypes in human obesity.
    Bähr I; Jahn J; Zipprich A; Pahlow I; Spielmann J; Kielstein H
    Immunol Res; 2018 Apr; 66(2):234-244. PubMed ID: 29560551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression.
    Zheng Y; Ma X; Su D; Zhang Y; Yu L; Jiang F; Zhou X; Feng Y; Ma F
    J Immunol Res; 2020; 2020():6243819. PubMed ID: 32322597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viewing Siglecs through the lens of tumor immunology.
    Fraschilla I; Pillai S
    Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.
    Daly J; Carlsten M; O'Dwyer M
    Front Immunol; 2019; 10():1047. PubMed ID: 31143186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells.
    Adeniji OS; Kuri-Cervantes L; Yu C; Xu Z; Ho M; Chew GM; Shikuma C; Tomescu C; George AF; Roan NR; Ndhlovu LC; Liu Q; Muthumani K; Weiner DB; Betts MR; Xiao H; Abdel-Mohsen M
    PLoS Pathog; 2021 Nov; 17(11):e1010034. PubMed ID: 34762717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.
    Jandus C; Boligan KF; Chijioke O; Liu H; Dahlhaus M; Démoulins T; Schneider C; Wehrli M; Hunger RE; Baerlocher GM; Simon HU; Romero P; Münz C; von Gunten S
    J Clin Invest; 2014 Apr; 124(4):1810-20. PubMed ID: 24569453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9.
    Rodriguez E; Boelaars K; Brown K; Eveline Li RJ; Kruijssen L; Bruijns SCM; van Ee T; Schetters STT; Crommentuijn MHW; van der Horst JC; van Grieken NCT; van Vliet SJ; Kazemier G; Giovannetti E; Garcia-Vallejo JJ; van Kooyk Y
    Nat Commun; 2021 Feb; 12(1):1270. PubMed ID: 33627655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The change of Siglec-9 expression in peripheral blood NK cells of SFTS patients can affect the function of NK cells.
    Zhang Y; Jin K; Dai Y; Hu N; Zhou T; Yang Z; Ding N; Zhang R; Xu R; Zhao J; Han Y; Zhu C; Zhu J; Li J
    Immunol Lett; 2023 Nov; 263():97-104. PubMed ID: 37865296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialylation pattern in lung epithelial cell line and Siglecs expression in monocytic THP-1 cells as cellular indicators of cigarette smoke - induced pathology in vitro.
    Wielgat P; Trofimiuk E; Czarnomysy R; Holownia A; Braszko JJ
    Exp Lung Res; 2018 Apr; 44(3):167-177. PubMed ID: 29781747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Developed NK-92MI Cell Line with Siglec-7
    Huang CH; Liao YJ; Fan TH; Chiou TJ; Lin YH; Twu YC
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
    Angata T; Hingorani R; Varki NM; Varki A
    J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siglec-7 Defines a Highly Functional Natural Killer Cell Subset and Inhibits Cell-Mediated Activities.
    Shao JY; Yin WW; Zhang QF; Liu Q; Peng ML; Hu HD; Hu P; Ren H; Zhang DZ
    Scand J Immunol; 2016 Sep; 84(3):182-90. PubMed ID: 27312286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.